2.74
1 yrs 3 m
0%
487.35 Crs
9.89
Large Growth
SIP 500 & Lumpsum 1000
sector funds
Sanjay Chawla,Ankeet Pandya
27-Jun-25
NA
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Investors understand that their principal will be at very high risk